Tylenol to clarify ad claims

Published on .

Print ads for Tylenol will be modified under an agreement between Johnson & Johnson's McNeil Consumer Products, New Brunswick, N.J., and the Council of Better Business Bureau's National Advertising Division. The Tylenol ads, from Saatchi & Saatchi Advertising, New York, will be changed to eliminate the implication that taking more aspirin than that prescribed for cardiovascular therapy is excessive, and to more accurately communicate the limited nature of Tylenol's "doctors recommend most" claim. The ads had been challenged by the Aspirin Foundation of America.

Copyright September 1997, Crain Communications Inc.

Most Popular
In this article: